account_name,fit,urgency,total,fit_reason,urgency_reason,urgency_source,trigger_summary,sec_matched_total,sec_examples,patent_matched_total,patent_examples,target_roles
AstraZeneca,5.0,3.0,22.836927038259464,CAR-T trial,RECRUITING in high urgency phase (PHASE1),clinicaltrials,trial_collaborator: A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus | trial_collaborator: Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma | trial_collaborator: Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma,0,[],0,[],"[""Clinical Scientist / Early Clinical Development Lead (Phase 1)"", ""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development""]"
Pfizer,4.0,3.0,20.66750714274709,molecule match: elranatamab,RECRUITING in high urgency phase (PHASE1),clinicaltrials,trial_collaborator: Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guide | trial_collaborator: Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma | trial_collaborator: A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elra,0,[],0,[],"[""Clinical Scientist / Early Clinical Development Lead (Phase 1)"", ""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development""]"
GSK,1.0,0.0,4.0,no trials,no trials and no relevant sec/patent signals,none,,0,[],0,[],"[""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development"", ""Clinical Scientist / Early Clinical Development Lead (Phase 1)""]"
